• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SD filed by Zoetis Inc.

    6/2/25 4:04:30 PM ET
    $ZTS
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ZTS alert in real time by email
    SD 1 zoetisformsd2024calendarye.htm SD Document



    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM SD
    Specialized Disclosure Report

    Zoetis Inc.
    (Exact name of registrant as specified in its charter)

    Delaware
    001-35797
    46-0696167
    (State or other jurisdiction
    (Commission File Number)
    (I.R.S. Employer
    Identification No.)
    of incorporation or organization)
    10 Sylvan Way, Parsippany, NJ07054
    (Address of principal executive offices)(Zip code)

    Roxanne Lagano
    Executive Vice President,
    General Counsel and Corporate Secretary
    (973) 822-7000
    (Name and telephone number, including area code,
    of the person to contact in connection with this report.)

    Check the appropriate box below to indicate the rule pursuant to which this Form is being submitted, and provide the period to which the information in this Form applies:


    ☒
    Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2024.
    ☐
    Rule 13q-1 under the Securities Exchange Act (17 CFR 240.13q-1) for the fiscal year ended ______.





    Section 1 - Conflict Minerals Disclosure

    Item 1.01. Conflict Minerals Disclosure and Report

    As provided for in Rule 13p-1 under the Securities Exchange Act of 1934, as amended, and Form SD, a Conflict Minerals Report is provided as an exhibit to this Form SD and is available at the Zoetis Inc. Internet website: www.zoetis.com. The information contained on our website is not incorporated by reference into this Form SD or our Conflict Minerals Report and should not be considered part of this report or the Conflict Minerals Report.

    Item 1.02. Exhibit

    The Conflict Minerals Report described in Item 1.01 is filed as Exhibit 1.01 to this Form SD.

    Section 2 - Resource Extraction Issuer Disclosure

    Item 2.01. Resource Extraction Issuer Disclosure and Report

    Not applicable.

    Section 3 - Exhibits

    Item 3.01. Exhibits
      
    Exhibit Number Description
      
    1.01
     Conflict Minerals Report for the calendar year ended December 31, 2024.







    SIGNATURE
    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.
    ZOETIS INC.
    (Registrant)
    By:/s/ Roxanne Lagano
    Name:Roxanne Lagano
    Title:Executive Vice President, General Counsel and Corporate Secretary
    Date: June 2, 2025


    Get the next $ZTS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ZTS

    DatePrice TargetRatingAnalyst
    6/18/2025$160.00Buy → Hold
    Stifel
    12/2/2024$215.00Outperform
    Leerink Partners
    7/25/2024$220.00Buy
    BTIG Research
    1/12/2024$195.00 → $215.00Buy
    Stifel
    12/19/2023$230.00Buy
    Jefferies
    12/7/2023$237.00Outperform
    Exane BNP Paribas
    9/6/2023$230.00Buy
    HSBC Securities
    7/12/2022$205.00Overweight
    Piper Sandler
    More analyst ratings

    $ZTS
    SEC Filings

    See more
    • SEC Form 11-K filed by Zoetis Inc.

      11-K - Zoetis Inc. (0001555280) (Filer)

      6/23/25 4:44:01 PM ET
      $ZTS
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form SD filed by Zoetis Inc.

      SD - Zoetis Inc. (0001555280) (Filer)

      6/2/25 4:04:30 PM ET
      $ZTS
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Zoetis Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - Zoetis Inc. (0001555280) (Filer)

      5/22/25 4:26:50 PM ET
      $ZTS
      Biotechnology: Pharmaceutical Preparations
      Health Care